Squarepoint
PRQR icon

Squarepoint’s ProQR Therapeutics PRQR Stock Holding History

Squarepoint’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,518
Closed -$51.1K – 4860
2026
Q1 		$51.1K Buy
+31,518
New +$51.7K ﹤0.01% 4139
2025
Q2 		– Sell
-112,463
Closed -$150K – 4946
2025
Q1 		$150K Buy
112,463
+29,349
+35% +$62.5K ﹤0.01% 4108
2024
Q4 		$220K Buy
83,114
+11,623
+16% +$36.9K ﹤0.01% 4394
2024
Q3 		$130K Sell
71,491
-13,242
-16% -$24.9K ﹤0.01% 3812
2024
Q2 		$141K Sell
84,733
-67,769
-44% -$132K ﹤0.01% 3737
2024
Q1 		$346K Buy
152,502
+24,328
+19% +$52K ﹤0.01% 3297
2023
Q4 		$254K Sell
128,174
-4,204
-3% -$6.46K ﹤0.01% 3459
2023
Q3 		$172K Sell
132,378
-1,764
-1% -$2.77K ﹤0.01% 3460
2023
Q2 		$217K Buy
+134,142
New +$262K ﹤0.01% 3172
2022
Q2 		– Sell
-49,878
Closed -$45K – 3265
2022
Q1 		$45K Buy
+49,878
New +$167K ﹤0.01% 2680
2021
Q4 		– Sell
-18,049
Closed -$151K – 3452
2021
Q3 		$151K Buy
+18,049
New +$118K ﹤0.01% 2591
2021
Q2 		– Sell
-75,196
Closed -$497K – 3598
2021
Q1 		$497K Buy
75,196
+55,391
+280% +$283K ﹤0.01% 2026
2020
Q4 		$83K Buy
+19,805
New +$83.6K ﹤0.01% 2746
2019
Q1 		– Sell
-10,700
Closed -$169K – 2379
2018
Q4 		$169K Buy
+10,700
New +$196K ﹤0.01% 1731

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Squarepoint's PRQR Position: Q2 2026 in Review

Squarepoint sold out of ProQR Therapeutics (PRQR) in Q2 2026, closing a stake of 31,518 shares — an estimated $51.1K sold.

Squarepoint first reported a position in PRQR in Q4 2018 and held it in 14 quarters. The position peaked at $497K in Q1 2021. 70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • Squarepoint reported no remaining ProQR Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 31,518 ProQR Therapeutics shares in Q2 2026, an estimated $51.1K.
  • Squarepoint first reported a position in ProQR Therapeutics in Q4 2018 and held it in 14 quarters.
  • Squarepoint's ProQR Therapeutics position peaked at $497K in Q1 2021.
  • 70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.